Agoracom: Small Cap Investment - Zenith Epigenetics - Re: AGM - Jan 7, 2016

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Back To Forum List View

AGM - Jan 7, 2016 - Details

masila

Jan 08, 2016 10:43AM

Re: AGM - Jan 7, 2016 - Details

KayakerBC

Jan 08, 2016 11:24AM

Re: AGM - Jan 7, 2016 - Details

chicagoest

Jan 08, 2016 12:52PM

Re: AGM - Jan 7, 2016 - Details

BearDownAZ

Jan 08, 2016 01:38PM

jbuffett62

Rank: Treasurer [?]

Points: 480 [?]

Votes: 13 Score: 2.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: AGM - Jan 7, 2016 - Details

in response to

Re: AGM - Jan 7, 2016 - Details

BearDownAZ

posted on Jan 08, 2016 01:46PM

I realize both companies were always potentially on the selling block but does it strike you as though the sale of RVX has been somewhat ramped up(or both?)?

Thanks

3 Recommendations

Re: AGM - Jan 7, 2016 - Details

chicagoest

Jan 08, 2016 02:02PM

Re: AGM - Jan 7, 2016 - Details

Jkj193741

Jan 08, 2016 02:50PM

Re: AGM - Jan 7, 2016 - Details

KayakerBC

Jan 08, 2016 04:27PM

Re: AGM - Jan 7, 2016 - Details

Jkj193741